Ranbaxy pleads guilty, to pay $500 million in U.S. settlement

Administrator 0 Reuters Health
Print Email

(Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with the U.S. Department of Justice.


Read Full Article


You can contact us at: